Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults-Reference-Cited by-同舟云学术

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

Published:2021-05-26 Issue: Volume: Page:
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Al Kaabi Nawal¹,Zhang Yuntao²,Xia Shengli³,Yang Yunkai²,Al Qahtani Manaf M.⁴,Abdulrazzaq Najiba⁵,Al Nusair Majed⁶,Hassany Mohamed⁷,Jawad Jaleela S.⁸,Abdalla Jehad¹,Hussein Salah Eldin¹,Al Mazrouei Shamma K.¹,Al Karam Maysoon¹,Li Xinguo⁹,Yang Xuqin²,Wang Wei¹⁰,Lai Bonan²,Chen Wei⁹,Huang Shihe⁹,Wang Qian²,Yang Tian²,Liu Yang²,Ma Rui¹⁰,Hussain Zaidoon M.¹,Khan Tehmina¹,Saifuddin Fasihuddin Mohammed¹,You Wangyang³,Xie Zhiqiang³,Zhao Yuxiu¹⁰,Jiang Zhiwei¹¹,Zhao Guoqing¹¹,Zhang Yanbo¹²,Mahmoud Sally¹³,ElTantawy Islam¹³,Xiao Peng¹³,Koshy Ashish¹²,Zaher Walid Abbas¹³,Wang Hui¹⁰,Duan Kai⁹,Pan An¹²,Yang Xiaoming²⁹

Affiliation:

1. Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates

2. China National Biotec Group Company Limited, Beijing, China

3. Henan Province Center for Disease Control and Prevention, Zhengzhou, Henan, China

4. Bahrain Defence Force Royal Medical Services, Military Hospital, Kingdom of Bahrain

5. Ministry of Health and Prevention, Abu Dhabi, United Arab Emirates

6. Prince Hamza Hospital, Amman, Jordan

7. Ministry of Health, Cairo, Egypt

8. Ministry of Health, Kingdom of Bahrain

9. National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co, Ltd, Wuhan, Hubei, China

10. Beijing Institute of Biological Products Co, Ltd, Beijing, China

11. Beijing Key-Tech Statistical Consulting Co, Ltd, Beijing, China

12. Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

13. G42 Healthcare, Abu Dhabi, United Arab Emirates

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2780562/jama_al_kaabi_2021_oi_210057_1621966324.79302.pdf

Reference24 articles.

1. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.;Kyriakidis;NPJ Vaccines,2021

2. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials.;Xia;JAMA,2020

3. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.;Xia;Lancet Infect Dis,2021

4. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2.;Wang;Cell,2020